UV GERMI SA (ALUVI.PA) Fundamental Analysis & Valuation

EPA:ALUVI • FR0011898584

Current stock price

2.25 EUR
-0.01 (-0.44%)
Last:

This ALUVI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALUVI.PA Profitability Analysis

1.1 Basic Checks

  • ALUVI had positive earnings in the past year.
  • Of the past 5 years ALUVI 4 years were profitable.
  • ALUVI had a negative operating cash flow in each of the past 5 years.
ALUVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALUVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 500K -500K

1.2 Ratios

  • ALUVI's Return On Assets of 5.27% is fine compared to the rest of the industry. ALUVI outperforms 71.03% of its industry peers.
  • With a Return On Equity value of 5.80%, ALUVI perfoms like the industry average, outperforming 46.73% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.15%, ALUVI is not doing good in the industry: 69.16% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 5.27%
ROE 5.8%
ROIC 3.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUVI.PA Yearly ROA, ROE, ROICALUVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2023 2024 0 5 -5 -10

1.3 Margins

  • ALUVI's Profit Margin of 7.75% is fine compared to the rest of the industry. ALUVI outperforms 79.44% of its industry peers.
  • In the last couple of years the Profit Margin of ALUVI has grown nicely.
  • With a Operating Margin value of 5.61%, ALUVI perfoms like the industry average, outperforming 46.73% of the companies in the same industry.
  • ALUVI has a Gross Margin of 51.20%. This is in the better half of the industry: ALUVI outperforms 68.22% of its industry peers.
  • ALUVI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.61%
PM (TTM) 7.75%
GM 51.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.03%
GM growth 3Y3.79%
GM growth 5Y5.14%
ALUVI.PA Yearly Profit, Operating, Gross MarginsALUVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ALUVI.PA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ALUVI remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, ALUVI has more shares outstanding
  • Compared to 1 year ago, ALUVI has an improved debt to assets ratio.
ALUVI.PA Yearly Shares OutstandingALUVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 1M 2M 3M
ALUVI.PA Yearly Total Debt VS Total AssetsALUVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 4.40 indicates that ALUVI is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ALUVI (4.40) is better than 89.72% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that ALUVI is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.00, ALUVI belongs to the best of the industry, outperforming 96.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.4
ROIC/WACCN/A
WACCN/A
ALUVI.PA Yearly LT Debt VS Equity VS FCFALUVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

  • ALUVI has a Current Ratio of 7.88. This indicates that ALUVI is financially healthy and has no problem in meeting its short term obligations.
  • ALUVI's Current ratio of 7.88 is amongst the best of the industry. ALUVI outperforms 99.07% of its industry peers.
  • A Quick Ratio of 5.51 indicates that ALUVI has no problem at all paying its short term obligations.
  • ALUVI's Quick ratio of 5.51 is amongst the best of the industry. ALUVI outperforms 99.07% of its industry peers.
Industry RankSector Rank
Current Ratio 7.88
Quick Ratio 5.51
ALUVI.PA Yearly Current Assets VS Current LiabilitesALUVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALUVI.PA Growth Analysis

3.1 Past

  • ALUVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.00%, which is quite impressive.
  • ALUVI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.53% yearly.
  • The Revenue has decreased by -9.66% in the past year.
  • Measured over the past years, ALUVI shows a small growth in Revenue. The Revenue has been growing by 6.64% on average per year.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y42.53%
EPS Q2Q%-26.67%
Revenue 1Y (TTM)-9.66%
Revenue growth 3Y10.44%
Revenue growth 5Y6.64%
Sales Q2Q%-22.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALUVI.PA Yearly Revenue VS EstimatesALUVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALUVI.PA Yearly EPS VS EstimatesALUVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALUVI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.50 indicates a correct valuation of ALUVI.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALUVI indicates a rather cheap valuation: ALUVI is cheaper than 83.18% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, ALUVI is valued rather cheaply.
Industry RankSector Rank
PE 12.5
Fwd PE N/A
ALUVI.PA Price Earnings VS Forward Price EarningsALUVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALUVI.PA Per share dataALUVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALUVI.PA Dividend Analysis

5.1 Amount

  • No dividends for ALUVI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALUVI.PA Fundamentals: All Metrics, Ratios and Statistics

UV GERMI SA

EPA:ALUVI (3/20/2026, 7:00:00 PM)

2.25

-0.01 (-0.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-06
Earnings (Next)N/A
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners26.64%
Ins Owner ChangeN/A
Market Cap5.47M
Revenue(TTM)7.48M
Net Income(TTM)580.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.5
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.64
EV/EBITDA N/A
EPS(TTM)0.18
EY8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.08
BVpS4.01
TBVpS3.51
PEG (NY)N/A
PEG (5Y)0.29
Graham Number4.03
Profitability
Industry RankSector Rank
ROA 5.27%
ROE 5.8%
ROCE 4.29%
ROIC 3.15%
ROICexc 3.15%
ROICexgc 3.6%
OM 5.61%
PM (TTM) 7.75%
GM 51.2%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.03%
GM growth 3Y3.79%
GM growth 5Y5.14%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.88
Quick Ratio 5.51
Altman-Z 4.4
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y42.53%
EPS Q2Q%-26.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.66%
Revenue growth 3Y10.44%
Revenue growth 5Y6.64%
Sales Q2Q%-22.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

UV GERMI SA / ALUVI.PA Fundamental Analysis FAQ

What is the fundamental rating for ALUVI stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALUVI.PA.


Can you provide the valuation status for UV GERMI SA?

ChartMill assigns a valuation rating of 2 / 10 to UV GERMI SA (ALUVI.PA). This can be considered as Overvalued.


What is the profitability of ALUVI stock?

UV GERMI SA (ALUVI.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of UV GERMI SA (ALUVI.PA) stock?

The Price/Earnings (PE) ratio for UV GERMI SA (ALUVI.PA) is 12.5 and the Price/Book (PB) ratio is 0.56.